Erik Gaitzsch

484 total citations
8 papers, 109 citations indexed

About

Erik Gaitzsch is a scholar working on Molecular Biology, Immunology and Rheumatology. According to data from OpenAlex, Erik Gaitzsch has authored 8 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Rheumatology. Recurrent topics in Erik Gaitzsch's work include Immune Response and Inflammation (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Erik Gaitzsch is often cited by papers focused on Immune Response and Inflammation (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Erik Gaitzsch collaborates with scholars based in Germany. Erik Gaitzsch's co-authors include Joachim Pircher, Hanna Mannell, Florian Krötz, Thomas Czermak, Markus Wörnle, Andrea Ribeiro, Monika Merkle, Stefan Alig, Markus Niemeyer and Hae‐Young Sohn and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Autoimmunity.

In The Last Decade

Erik Gaitzsch

7 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Gaitzsch Germany 7 44 42 22 20 11 8 109
Shuqiang Li United States 3 61 1.4× 55 1.3× 11 0.5× 13 0.7× 11 1.0× 4 140
Mengbiao Guo China 6 51 1.2× 31 0.7× 16 0.7× 29 1.4× 7 0.6× 19 101
Jonathan Lindstrom-Vautrin United States 9 96 2.2× 16 0.4× 12 0.5× 11 0.6× 11 1.0× 13 177
Ewa Bertolini France 6 38 0.9× 13 0.3× 12 0.5× 11 0.6× 17 1.5× 8 109
Nicholas Chun United States 7 46 1.0× 143 3.4× 24 1.1× 7 0.3× 17 1.5× 17 193
Eva‐Maria Jacobsen Germany 7 46 1.0× 67 1.6× 16 0.7× 10 0.5× 8 0.7× 17 141
Alison J. Potter Australia 6 34 0.8× 19 0.5× 31 1.4× 6 0.3× 8 0.7× 17 97
Felix A. Radtke Germany 5 27 0.6× 43 1.0× 23 1.0× 10 0.5× 7 0.6× 6 91
Stefania Gentile Italy 4 52 1.2× 153 3.6× 9 0.4× 14 0.7× 18 1.6× 4 196
Chiara Pirillo United Kingdom 7 48 1.1× 51 1.2× 29 1.3× 20 1.0× 20 1.8× 10 136

Countries citing papers authored by Erik Gaitzsch

Since Specialization
Citations

This map shows the geographic impact of Erik Gaitzsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Gaitzsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Gaitzsch more than expected).

Fields of papers citing papers by Erik Gaitzsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Gaitzsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Gaitzsch. The network helps show where Erik Gaitzsch may publish in the future.

Co-authorship network of co-authors of Erik Gaitzsch

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Gaitzsch. A scholar is included among the top collaborators of Erik Gaitzsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Gaitzsch. Erik Gaitzsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gaitzsch, Erik & Oliver Weigert. (2020). Neue Therapien für Patienten mit Non-Hodgkin-Lymphomen. TumorDiagnostik & Therapie. 41(4). 240–245.
2.
Gaitzsch, Erik, Thomas Czermak, Andrea Ribeiro, et al.. (2017). Double-stranded DNA induces a prothrombotic phenotype in the vascular endothelium. Scientific Reports. 7(1). 1112–1112. 13 indexed citations
3.
Pircher, Joachim, Monika Merkle, Thomas Czermak, et al.. (2016). Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C. Cellular and Molecular Immunology. 14(12). 986–996. 12 indexed citations
4.
Pircher, Joachim, Thomas Czermak, Erik Gaitzsch, et al.. (2016). The proteasome regulates collagen-induced platelet aggregation via nuclear-factor-kappa-B (NFĸB) activation. Thrombosis Research. 148. 15–22. 23 indexed citations
5.
Merkle, Monika, Joachim Pircher, Hanna Mannell, et al.. (2015). LL37 inhibits the inflammatory endothelial response induced by viral or endogenous DNA. Journal of Autoimmunity. 65. 19–29. 13 indexed citations
6.
Alig, Stefan, Joachim Pircher, Erik Gaitzsch, et al.. (2015). The Tyrosine Phosphatase SHP-1 Regulates Hypoxia Inducible Factor-1α (HIF-1α) Protein Levels in Endothelial Cells under Hypoxia. PLoS ONE. 10(3). e0121113–e0121113. 20 indexed citations
7.
Pircher, Joachim, Thomas Czermak, Monika Merkle, et al.. (2014). Hepatitis C Virus Induced Endothelial Inflammatory Response Depends on the Functional Expression of TNFα Receptor Subtype 2. PLoS ONE. 9(11). e113351–e113351. 15 indexed citations
8.
Koch, Elisabeth, Joachim Pircher, Thomas Czermak, et al.. (2013). The Endothelial Tyrosine Phosphatase SHP-1 Plays an Important Role for Vascular Haemostasis in TNFα-Induced InflammationIn Vivo. Mediators of Inflammation. 2013. 1–11. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026